RecruitingNCT06374745
An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol
Sponsor
University Hospital, Basel, Switzerland
Enrollment
500 participants
Start Date
Jan 2, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.
Eligibility
Inclusion Criteria5
- status post breast cancer or status post another type of cancer or status post no cancer
- chronic lymphedema - lymphedema lasting over three months - present prior to surgical treatment
- one type of surgical procedure for treatment of chronic lymphedema or a combination of surgical procedures for treatment of chronic lymphedema was performed
- one or any combination of the following surgical procedures was used in each individual patient: Lymph Node-Vein Anastomosis (LNVA) , Lymphaticovenous Anastomosis (LVA), Tumescent Liposuction (TL), Vascularized Lymph Node Transfer (VLNT) and/or Water-Assisted Liposuction (WAL)
- loss to follow-up (data not successfully collected)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06374745
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location